 Christina Lisk
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Porins | 4 | 2021 | 17 | 1.630 |
Why?
| | Adjuvants, Immunologic | 3 | 2021 | 238 | 1.340 |
Why?
| | Anemia, Sickle Cell | 5 | 2025 | 266 | 1.300 |
Why?
| | beta-Thalassemia | 2 | 2025 | 37 | 1.020 |
Why?
| | Dendritic Cells, Follicular | 2 | 2021 | 7 | 0.840 |
Why?
| | Ovalbumin | 2 | 2021 | 196 | 0.830 |
Why?
| | Sialic Acid Binding Ig-like Lectin 1 | 1 | 2021 | 7 | 0.700 |
Why?
| | Immunogenicity, Vaccine | 1 | 2021 | 34 | 0.690 |
Why?
| | Alum Compounds | 1 | 2021 | 27 | 0.690 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2021 | 143 | 0.670 |
Why?
| | Toll-Like Receptors | 1 | 2021 | 189 | 0.640 |
Why?
| | Germinal Center | 1 | 2020 | 66 | 0.640 |
Why?
| | Hemoglobins | 4 | 2017 | 361 | 0.630 |
Why?
| | Macrophages | 2 | 2023 | 1561 | 0.510 |
Why?
| | Altitude Sickness | 2 | 2014 | 149 | 0.460 |
Why?
| | Hemopexin | 2 | 2025 | 28 | 0.450 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2019 | 105 | 0.420 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2013 | 94 | 0.380 |
Why?
| | Vasodilator Agents | 1 | 2013 | 330 | 0.350 |
Why?
| | Transcriptional Activation | 1 | 2013 | 378 | 0.350 |
Why?
| | Haptoglobins | 2 | 2025 | 56 | 0.340 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 630 | 0.320 |
Why?
| | Hypertension, Pulmonary | 5 | 2025 | 1936 | 0.320 |
Why?
| | Antigen-Presenting Cells | 2 | 2019 | 159 | 0.270 |
Why?
| | Endothelial Cells | 1 | 2013 | 816 | 0.270 |
Why?
| | Iron | 3 | 2025 | 323 | 0.260 |
Why?
| | Mice | 10 | 2025 | 18048 | 0.260 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5887 | 0.220 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 30 | 0.220 |
Why?
| | Animals | 14 | 2025 | 37657 | 0.220 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 56 | 0.220 |
Why?
| | Heme | 1 | 2025 | 76 | 0.220 |
Why?
| | Proteomics | 3 | 2025 | 1134 | 0.200 |
Why?
| | Spleen | 1 | 2025 | 525 | 0.190 |
Why?
| | Exercise Tolerance | 1 | 2025 | 280 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 254 | 0.190 |
Why?
| | Meningococcal Infections | 2 | 2019 | 30 | 0.180 |
Why?
| | Vaccination | 2 | 2021 | 1467 | 0.180 |
Why?
| | Clodronic Acid | 1 | 2021 | 18 | 0.170 |
Why?
| | Pulmonary Artery | 3 | 2017 | 1114 | 0.170 |
Why?
| | Lung | 4 | 2025 | 4134 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 152 | 0.170 |
Why?
| | Monocytes | 1 | 2023 | 579 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 483 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2021 | 3068 | 0.160 |
Why?
| | Immunoglobulin G | 2 | 2021 | 900 | 0.150 |
Why?
| | Disease Progression | 2 | 2023 | 2793 | 0.130 |
Why?
| | Cross-Priming | 1 | 2017 | 16 | 0.130 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 33 | 0.130 |
Why?
| | Liver | 1 | 2025 | 1819 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 1 | 2017 | 120 | 0.120 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4404 | 0.120 |
Why?
| | Antigen Presentation | 1 | 2017 | 220 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 286 | 0.110 |
Why?
| | Vaccines | 1 | 2020 | 406 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2020 | 858 | 0.110 |
Why?
| | Signal Transduction | 2 | 2021 | 5144 | 0.110 |
Why?
| | Chloride Channels | 1 | 2014 | 35 | 0.110 |
Why?
| | Catalase | 1 | 2013 | 134 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 82 | 0.100 |
Why?
| | Vascular Diseases | 2 | 2015 | 244 | 0.100 |
Why?
| | Permeability | 1 | 2013 | 166 | 0.100 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 1086 | 0.100 |
Why?
| | Rats | 4 | 2015 | 5629 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 245 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 261 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 276 | 0.090 |
Why?
| | Cerebellum | 1 | 2013 | 218 | 0.090 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 352 | 0.090 |
Why?
| | Cell Line | 2 | 2015 | 2885 | 0.090 |
Why?
| | Oxidative Stress | 3 | 2025 | 1330 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 859 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 692 | 0.080 |
Why?
| | Antioxidants | 1 | 2013 | 595 | 0.080 |
Why?
| | Hypoxia | 2 | 2015 | 1164 | 0.080 |
Why?
| | Lung Diseases | 2 | 2015 | 794 | 0.080 |
Why?
| | Neisseria meningitidis | 2 | 2019 | 25 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2014 | 951 | 0.070 |
Why?
| | Humans | 9 | 2025 | 141187 | 0.060 |
Why?
| | Inflammation | 2 | 2023 | 2890 | 0.060 |
Why?
| | Male | 8 | 2025 | 69783 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2013 | 2828 | 0.060 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 64 | 0.060 |
Why?
| | Lipid Peroxidation | 2 | 2017 | 150 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 3 | 2015 | 2520 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 181 | 0.050 |
Why?
| | Hemolysis | 1 | 2025 | 201 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 142 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 283 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 321 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 450 | 0.050 |
Why?
| | Thrombin | 1 | 2023 | 170 | 0.050 |
Why?
| | Female | 5 | 2020 | 75515 | 0.040 |
Why?
| | Cytokines | 2 | 2019 | 2098 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2180 | 0.040 |
Why?
| | Erythrocytes | 1 | 2025 | 699 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 704 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2504 | 0.040 |
Why?
| | Antibodies, Bacterial | 1 | 2019 | 146 | 0.040 |
Why?
| | Animals, Genetically Modified | 1 | 2019 | 242 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 689 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 16 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1010 | 0.030 |
Why?
| | Lymphoid Tissue | 1 | 2017 | 81 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 146 | 0.030 |
Why?
| | Endosomes | 1 | 2017 | 143 | 0.030 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2014 | 14 | 0.030 |
Why?
| | Acetazolamide | 1 | 2014 | 25 | 0.030 |
Why?
| | Tanzania | 1 | 2014 | 59 | 0.030 |
Why?
| | Immunization | 1 | 2017 | 406 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1752 | 0.030 |
Why?
| | Mountaineering | 1 | 2014 | 40 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 145 | 0.030 |
Why?
| | Antiemetics | 1 | 2014 | 48 | 0.030 |
Why?
| | Commerce | 1 | 2014 | 80 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 85 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2015 | 364 | 0.030 |
Why?
| | Travel | 1 | 2014 | 136 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 412 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.020 |
Why?
| | Vascular Remodeling | 1 | 2015 | 193 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 32 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2012 | 34 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 792 | 0.020 |
Why?
| | Spin Labels | 1 | 2012 | 52 | 0.020 |
Why?
| | Cell Movement | 1 | 2017 | 990 | 0.020 |
Why?
| | Dexamethasone | 1 | 2014 | 380 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 857 | 0.020 |
Why?
| | Cardiac Output | 1 | 2012 | 177 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 396 | 0.020 |
Why?
| | Data Collection | 1 | 2014 | 661 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2239 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 918 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 339 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2019 | 2002 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1234 | 0.020 |
Why?
| | Oxygen | 1 | 2014 | 993 | 0.020 |
Why?
| | Pneumonia | 1 | 2015 | 656 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2012 | 900 | 0.020 |
Why?
| | Hemodynamics | 1 | 2012 | 1100 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4208 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1748 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1482 | 0.010 |
Why?
| | Child | 1 | 2023 | 22308 | 0.010 |
Why?
| | Adult | 1 | 2023 | 39177 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 16273 | 0.010 |
Why?
|
|
Lisk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|